Registry for patients receiving heart valve surgery products
Official title: Medtronic Cardiac Surgery Post Market Clinical Follow-up Registry
Run by Medtronic Cardiac Surgery · NCT04073420 · Data updated 2026-11-12
This study is tracking how well heart valve repair and replacement products work and are tolerated by patients who have had these surgeries.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 2700 (estimated) |
| Sponsor | Medtronic Cardiac Surgery Industry-sponsored |
| Locations | 26 sites (Marietta, Georgia and 25 other locations) |
| Status | Recruiting |
| Started | December 2, 2019 |
| Main results expected | December 31, 2039 |
| Study ends | December 31, 2039 |
| Registry record updated | September 25, 2026 |
| Trial ID | NCT04073420 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients who are receiving or are intended to receive surgical heart valve repair or replacement products.
✕Probably not a fit
Patients who are inaccessible for follow-up or are involved in other investigational studies may not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry is designed to monitor the safety and effectiveness of surgical heart valve repair and replacement products in patients. It collects data from individuals who are either currently receiving or have received these products, ensuring ongoing post-market surveillance. The registry aims to gather comprehensive information that can help improve patient outcomes and inform future medical practices related to heart valve treatments.
Why it matters
Potential benefit: If successful, this registry could enhance the understanding of heart valve surgery outcomes and improve patient care.
How similar studies have gone: Other post-market surveillance registries have shown success in improving patient outcomes and safety monitoring for medical devices.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements 2. Patient has or is intended to receive or be treated with an eligible product 3. Patient is within enrollment window of treatment/therapy received at the time of their initial Registry enrollment, or meets criteria for retrospective enrollment Exclusion Criteria: 1. Patient who is, or is expected to be, inaccessible for follow-up 2. Patient prohibited from participation by local law 3. Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or device study that may confound results
Where it's running
-
WellStar Kennestone Hospital
Marietta, Georgia, United States Recruiting -
University of Michigan
Ann Arbor, Michigan, United States Recruiting -
Mount Sinai Medical Center
New York, New York, United States Recruiting -
Saint Josephs Hospital Health Center
Syracuse, New York, United States Recruiting -
Duke University Medical Center
Durham, North Carolina, United States Recruiting -
University Hospitals Cleveland
Cleveland, Ohio, United States Recruiting
Show 20 more locations
-
University of Pittsburgh Medical Center UPMC Presbyterian
Pittsburgh, Pennsylvania, United States Recruiting -
Baylor St. Luke's Medical Center
Houston, Texas, United States Recruiting -
The Heart Hospital Plano
Plano, Texas, United States Recruiting -
Inova
Falls Church, Virginia, United States Recruiting -
Allgemeines Krankenhaus - Universitätskliniken Wien
Vienna, Austria Recruiting -
UZ Leuven
Leuven, Belgium Recruiting -
Hôpital Haut-Lévêque - CHU de Bordeaux
Pessac, France Recruiting -
Schüchtermann-Klinik
Bad Rothenfelde, Germany Recruiting -
Herzzentrum Dresden GmbH Universitätsklinik
Dresden, Germany Recruiting -
Universitätsklinikum Düsseldorf
Düsseldorf, Germany Recruiting -
Albertinen-Herz- und Gefäßzentrum
Hamburg, Germany Recruiting -
Herzzentrum Leipzig
Leipzig, Germany Recruiting -
Deutsches Herzzentrum München Klinik an der TU München
München, Germany Recruiting -
Onassis Cardiac Surgery Center
Athens, Greece Recruiting -
Ospedale Pasquinucci Massa
Massa, Italy Recruiting -
IRCCS Policlinico
San Donato, Italy Recruiting -
Leids Universitair Medisch Centrum
Leiden, Netherlands Recruiting -
Hospital Regional Universitario Carlos Haya Málaga - Hospital General
Málaga, Spain Recruiting -
Inselspital - Universitätsspital Bern
Bern, Switzerland Recruiting -
Saint Francis Hospital
Roslyn, New York, United States Withdrawn
Study contacts
- Study coordinator: Franceen Maroney
- Email: rs.hvtpmcfregistry@medtronic.com
- Phone: 1-800-328-2518
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nonintubated anesthesia for adults undergoing cardiac surgery with bypass
This trial tests a nonintubated airway approach with the goal of seeing if avoiding endotracheal intubation during elective valve or bypass surgery can reduce lung problems and help patients recover faster.
-
HemoCept device data collection during diagnostic right heart catheterization
This pilot will collect HemoCept device readings from adults having diagnostic right heart catheterization to see how the device records heart pressures.
-
Valvular Heart Disease Registry Focusing on Gender Differences
This registry will track care and outcomes for adults with valvular heart disease to see if there are gender differences from hospital admission through the first outpatient follow-up.
-
Asia‑Pacific registry of mitral and tricuspid valve‑in‑valve and valve‑in‑ring procedures
Collecting medical data from adults across the Asia‑Pacific who have had—or plan to have—mitral or tricuspid valve‑in‑valve or valve‑in‑ring procedures with a balloon‑expandable valve to see how patients do.
-
Long-term outcomes of the Mosaic mitral valve in patients under 65
This study looks at how well the Mosaic mitral valve works over time in people under 65 who have had valve replacement surgery.
-
Transplanting heart valves from donors into patients who need them
This study is testing if heart valves from donors can help kids and young adults who need valve replacements by providing a solution that grows with them and reduces the need for more surgeries later on.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.